Cue Biopharma
89 hedge funds and large institutions have $216M invested in Cue Biopharma in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.67% less ownership
Funds ownership: 61.78% → 59.11% (-2.7%)
6% less capital invested
Capital invested by funds: $229M → $216M (-$13.5M)
52% less call options, than puts
Call options by funds: $814K | Put options by funds: $1.68M
Holders
89
Holding in Top 10
2
Calls
$814K
Puts
$1.68M
Top Buyers
| 1 | +$5.41M | |
| 2 | +$4.27M | |
| 3 | +$1.76M | |
| 4 |
Morgan Stanley
New York
|
+$1.26M |
| 5 |
BL
Bleichroeder LP
New York
|
+$1.17M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$2.42M | |
| 3 | -$1.43M | |
| 4 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$1.17M |
| 5 |
BlackRock
New York
|
-$1.15M |